Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Piramal Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543635NSE Symbol: PPLPHARMAP/E(TTM):35.23
ISIN Demat:INE0DK501011Div & Yield %:0.07EPS(TTM):5.41
Book Value(Rs):56.1026791Market Cap ( Cr.):25335.47Face Value(Rs):10
    Change Company 
Date Headline
29-Jul-25 Piramal Pharma grants 20,20,507 stock options
29-Jul-25 Piramal Pharma reports consolidated net loss of Rs81.70 crore in the June 2025 quarter
29-Jul-25 Piramal Pharma posts loss of Rs82 crore in Q1; EBITDA margin declines to 9%
28-Jul-25 Piramal Pharma Ltd - Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025
22-Jul-25 Piramal Pharma to sell its decommissioned unit in MIDC, Thane for Rs8.50 cr
21-Jul-25 Piramal Pharma receives upgrade in LT credit ratings
19-Jul-25 Piramal Pharma to announce Quarterly Result
18-Jul-25 Piramal Pharma Ltd - Piramal Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
18-Jul-25 Piramal Pharma Ltd - Piramal Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
10-Jul-25 Piramal Pharma Ltd - Announcement Under Regulation 30 (LODR) - ESG Rating
<< < 1 2 3 4   > >>